Advertisement

Topics

Adaptive Biotech, Janssen ally in diagnostics deal

15:40 EDT 28 Jun 2017 | Elsevier Business Intelligence

Adaptive Biotechnologies Corp. will use its next-generation sequencing-based clonoSEQ assay to measure minimal residual disea...

Original Article: Adaptive Biotech, Janssen ally in diagnostics deal

NEXT ARTICLE

More From BioPortfolio on "Adaptive Biotech, Janssen ally in diagnostics deal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...